510(k) Predicate Finder
Find potential predicate devices for your 510(k) submission. Enter a K-number to find all clearances with the same product code, a three-letter product code to browse clearances directly, or search by device name.
Radioimmunoassay, Kanamycin
Clinical Toxicology
Radioimmunoassay, Kanamycin is an in vitro diagnostic device that uses radioisotope-labeled antibodies to quantify kanamycin antibiotic concentrations in patient serum or plasma, enabling therapeutic drug monitoring to ensure effective dosing while minimizing the risk of nephrotoxic and ototoxic adverse effects. It is classified as FDA Class 2, indicating moderate risk; devices in this category are subject to general controls and special controls, and typically require 510(k) premarket notification demonstrating substantial equivalence to a predicate device. The product code is KJI, regulated under 21 CFR 862.3520, within the Clinical Toxicology medical specialty. This device is eligible for third-party review.
510(k) Clearances
6 matchesWhat is a Predicate Device?
A predicate device is a legally marketed device that a new 510(k) applicant uses to demonstrate substantial equivalence. The FDA's 510(k) pathway requires manufacturers to show that their device has the same intended use and similar technological characteristics as one or more predicate devices already cleared for commercial distribution.
Finding the right predicate is a critical step in 510(k) strategy. Manufacturers typically search for cleared devices with the same FDA product code, which groups devices by their intended use and regulatory classification. This tool helps you identify potential predicates by browsing all clearances within a product code.
Note that predicate devices must be legally marketed — they cannot be devices that were cleared but never commercialized, or devices subject to a mandatory recall. The determination of substantial equivalence considers intended use, technological characteristics, and performance data.